Perflutren [USAN]
Perflutren [USAN] - General Information
Perflutren [USAN], a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures, is comprised of lipid-coated microspheres filled with octafluoropropane(OFP) gas. When exposed to ultrasound waves, the microspheres resonate and "echo" strong signals back to the ultrasound machine. The difference in density between the gas-filled bubbles and the blood around them creates an increased level of contrast visible in the resulting ultrasound image. During echocardiography, activated Perflutren [USAN] enhances images of the inner edges or borders of the heart, producing an improved image that may enable physicians to better diagnose patients.
Pharmacology of Perflutren [USAN]
Perflutren [USAN], a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures, comprised of lipid-coated microspheres filled with octafluoropropane(OFP) gas. It provide contrast enhancement of the endocardial borders during echocardiography. The perflutren lipid microspheres exhibit lower acoustic impedance than blood and enhance the intrinsic backscatter of blood.
Perflutren [USAN] for patients
Perflutren [USAN] Interactions
No separate information available.
Perflutren [USAN] Contraindications
Activated DEFINITY should not be administered to patients with known hypersensitivity to octafluoropropane or in patients with known cardiac shunts.
Activated DEFINITY should not be administered by direct intra-arterial injection.
Additional information about Perflutren [USAN]
Perflutren [USAN] Indication: Use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
Mechanism Of Action: Perflutren [USAN] is comprised of gas-filled microspheres that are injected or infused into the body. When exposed to ultrasound waves, the microspheres resonate and "echo" strong signals back to the ultrasound machine. The difference in density between the gas-filled bubbles and the blood around them creates an increased level of contrast visible in the resulting ultrasound image. During echocardiography, activated Perflutren [USAN] enhances images of the inner edges or borders of the heart, producing an improved image that may enable physicians to better diagnose patients.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Perflutren
Synonyms: Not Available
Drug Category: Contrast Media; Ultrasound contrast agent
Drug Type: Small Molecule; Approved
Other Brand Names containing Perflutren: Definity; Freon 218; Genetron 218; Octafluoropropane; Perfluoropropane; Perfluoropropane 99+%; Perfluoropropaneminimum; Perflutren [USAN]; Propane, octafluoro-;
Absorption: Not Available
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: OFP is not metabolized. The phospholipid components of the microspheres are thought to be metabolized to free fatty acids.
Half Life: The mean half-life of OFP in blood 1.9 minutes
Dosage Forms of Perflutren [USAN]: Suspension Intravenous
Chemical IUPAC Name: 1,1,1,2,2,3,3,3-octafluoropropane
Chemical Formula: C3F8
Perflutren on Wikipedia: Not Available
Organisms Affected: Humans and other mammals
